NERV · Minerva Neurosciences Inc

-

-

Please sign in to comment on NERV

1 Comment

Admin
4 years ago

Minerva Neurosciences, Inc is currently in a long term downtrend where the price is trading 24.1% below its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.

Minerva Neurosciences, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has increased by 75.5% to $-7M since the same quarter in the previous year.

Finally, its free cash flow grew by 49.5% to $-7M since the same quarter in the previous year.

Based on the above factors, Minerva Neurosciences, Inc gets an overall score of 3/5.












© PyInvesting 2025

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy